Add to ORKGThis study aims to: Examine the adolescent PrEP prescribing practices and knowledge of family medicine physicians. Begin to identify areas that might be key targets for interventions which may lead to increased adolescent PrEP prescribing uptake.https://jdc.jefferson.edu/fmposters/1005/thumbnail.jp
BACKGROUND: In 2015, there were approximately 40,000 new HIV diagnoses in the United States. Pre-exp...
Background and objectivesLess than 10 percent of the more than one million people vulnerable to HIV ...
Preexposure prophylaxis (PrEP) is an innovative biomedical approach that has been used over the past...
Introduction: In the United States, individuals aged 13-24 made up 21% of new HIV infections in 2016...
Abstract Although HIV pre-exposure prophylaxis (PrEP) effectively and safely prevents HIV among adol...
Introduction. Attitudes of individuals who provide HIV caretowards prescribing Preexposure Prophylax...
ImportanceAdolescents represent a key population for implementing preexposure prophylaxis (PrEP) int...
Daisy Maria Machado,1 Alexandre Machado de Sant’Anna Carvalho,2 Rachel Riera3 1Disciplina de I...
HIV Pre-exposure Prophylaxis (PrEP), in which HIV-negative individuals receive antiretroviral medica...
HIV preexposure prophylaxis (PrEP) is an effective tool in preventing HIV infection and when taken c...
Background: On May 15, 2018, the Federal Drug Administration (FDA) approved once daily tenofovir/emt...
Please see the updated version of this presentation: Ohkura, Michael; Bonefant, Nicholas; and Upton,...
BACKGROUND:In 2015, there were approximately 40,000 new HIV diagnoses in the United States. Pre-expo...
HIV infections have been, and continue to be, a significant health concern for the United States. Th...
The United States’ initiative to End the HIV Epidemic by 2030 includes a primary goal to reduce new ...
BACKGROUND: In 2015, there were approximately 40,000 new HIV diagnoses in the United States. Pre-exp...
Background and objectivesLess than 10 percent of the more than one million people vulnerable to HIV ...
Preexposure prophylaxis (PrEP) is an innovative biomedical approach that has been used over the past...
Introduction: In the United States, individuals aged 13-24 made up 21% of new HIV infections in 2016...
Abstract Although HIV pre-exposure prophylaxis (PrEP) effectively and safely prevents HIV among adol...
Introduction. Attitudes of individuals who provide HIV caretowards prescribing Preexposure Prophylax...
ImportanceAdolescents represent a key population for implementing preexposure prophylaxis (PrEP) int...
Daisy Maria Machado,1 Alexandre Machado de Sant’Anna Carvalho,2 Rachel Riera3 1Disciplina de I...
HIV Pre-exposure Prophylaxis (PrEP), in which HIV-negative individuals receive antiretroviral medica...
HIV preexposure prophylaxis (PrEP) is an effective tool in preventing HIV infection and when taken c...
Background: On May 15, 2018, the Federal Drug Administration (FDA) approved once daily tenofovir/emt...
Please see the updated version of this presentation: Ohkura, Michael; Bonefant, Nicholas; and Upton,...
BACKGROUND:In 2015, there were approximately 40,000 new HIV diagnoses in the United States. Pre-expo...
HIV infections have been, and continue to be, a significant health concern for the United States. Th...
The United States’ initiative to End the HIV Epidemic by 2030 includes a primary goal to reduce new ...
BACKGROUND: In 2015, there were approximately 40,000 new HIV diagnoses in the United States. Pre-exp...
Background and objectivesLess than 10 percent of the more than one million people vulnerable to HIV ...
Preexposure prophylaxis (PrEP) is an innovative biomedical approach that has been used over the past...